drugset / Trial / NCT02905916

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

NCT02905916

Phase 4 Unknown 217 enrolled Peking University
NaSingle-groupOpen-labelPrevention

Summary

The purpose of the trail is to evaluate the efficacy and safety of PEG-rhG-CSF in primary prophylaxis and secondary prophylaxis of neutropenia after chemotherapy.

Timeline

Start
2016-06
Primary completion
2018-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Pegfilgrastim Protein / enzyme biologic